Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Lung transplantation at the University of Lund 1990-1995. Analysis of the first 39 consecutive patients

Eriksson, Leif LU ; Steen, Stig LU ; Koul, Bansi LU ; Mared, Lena LU and Solem, Jan Otto LU (1998) In Scandinavian Cardiovascular Journal 32(1). p.23-28
Abstract
Between 1990 and 1995 39 patients were lung transplanted at the University Hospital in Lund. This is a retrospective review of survival and lung function in these patients. There were 17 single-lung transplants (SLT), 21 double-lung transplants (DLT) and 1 heart-lung transplant (HLT). Seven patients died during the period, giving an overall survival of 82%. One-year survival according to Kaplan-Meier survival analysis was 87%, and 2-year survival was 83%. Vital capacity and forced expiratory volume in 1 s (FEV1) 1 year after transplantation were 91% and 100% of predicted, respectively, in the DLT group and 60% and 50% in the SLT group. Bronchiolitis obliterans syndrome (BOS) developed in 11 of the 35 patients (31%) surviving more than 6... (More)
Between 1990 and 1995 39 patients were lung transplanted at the University Hospital in Lund. This is a retrospective review of survival and lung function in these patients. There were 17 single-lung transplants (SLT), 21 double-lung transplants (DLT) and 1 heart-lung transplant (HLT). Seven patients died during the period, giving an overall survival of 82%. One-year survival according to Kaplan-Meier survival analysis was 87%, and 2-year survival was 83%. Vital capacity and forced expiratory volume in 1 s (FEV1) 1 year after transplantation were 91% and 100% of predicted, respectively, in the DLT group and 60% and 50% in the SLT group. Bronchiolitis obliterans syndrome (BOS) developed in 11 of the 35 patients (31%) surviving more than 6 months, 2/21 in the DLT group and 8/13 in the SLT group and in the patient with HLT. The median time until detection of BOS was 11 months after the operation (range 6-18 months). Working capacity 1 year after transplantation was 60% of predicted in the DLT group and 47% of predicted in the SLT group. Ventilatory capacity was no longer function limiting. Lung transplantation today is a therapeutic option with a good medium-term survival and good functional results in selected patients with severe lung disease. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Scandinavian Cardiovascular Journal
volume
32
issue
1
pages
23 - 28
publisher
Taylor & Francis
external identifiers
  • pmid:9536502
  • scopus:0031881974
ISSN
1651-2006
DOI
10.1080/14017439850140300
language
English
LU publication?
yes
id
2e6757af-5135-417c-ad7b-35401f99036d (old id 1113939)
date added to LUP
2016-04-01 17:09:02
date last changed
2022-01-29 00:44:35
@article{2e6757af-5135-417c-ad7b-35401f99036d,
  abstract     = {{Between 1990 and 1995 39 patients were lung transplanted at the University Hospital in Lund. This is a retrospective review of survival and lung function in these patients. There were 17 single-lung transplants (SLT), 21 double-lung transplants (DLT) and 1 heart-lung transplant (HLT). Seven patients died during the period, giving an overall survival of 82%. One-year survival according to Kaplan-Meier survival analysis was 87%, and 2-year survival was 83%. Vital capacity and forced expiratory volume in 1 s (FEV1) 1 year after transplantation were 91% and 100% of predicted, respectively, in the DLT group and 60% and 50% in the SLT group. Bronchiolitis obliterans syndrome (BOS) developed in 11 of the 35 patients (31%) surviving more than 6 months, 2/21 in the DLT group and 8/13 in the SLT group and in the patient with HLT. The median time until detection of BOS was 11 months after the operation (range 6-18 months). Working capacity 1 year after transplantation was 60% of predicted in the DLT group and 47% of predicted in the SLT group. Ventilatory capacity was no longer function limiting. Lung transplantation today is a therapeutic option with a good medium-term survival and good functional results in selected patients with severe lung disease.}},
  author       = {{Eriksson, Leif and Steen, Stig and Koul, Bansi and Mared, Lena and Solem, Jan Otto}},
  issn         = {{1651-2006}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{23--28}},
  publisher    = {{Taylor & Francis}},
  series       = {{Scandinavian Cardiovascular Journal}},
  title        = {{Lung transplantation at the University of Lund 1990-1995. Analysis of the first 39 consecutive patients}},
  url          = {{http://dx.doi.org/10.1080/14017439850140300}},
  doi          = {{10.1080/14017439850140300}},
  volume       = {{32}},
  year         = {{1998}},
}